US 10016432
Methanocarba derivatives of pseudoribose that inhibit adenosine kinase
granted A61KA61K31/519
Quick answer
US patent 10016432 (Methanocarba derivatives of pseudoribose that inhibit adenosine kinase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/519